Log in to save to my catalogue

The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARN...

The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARN...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4647475

The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment

About this item

Full title

The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment

Publisher

England: BioMed Central Ltd

Journal title

Radiation oncology (London, England), 2015-11, Vol.10 (230), p.229-229, Article 229

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Tumour hypoxia promotes radioresistance and is associated with poor prognosis. The transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT), also designated as Hypoxia-inducible factor (HIF)-1β, is part of the HIF pathway which mediates cellular adaptations to oxygen deprivation and facilitates tumour progression. The subunits HIF...

Alternative Titles

Full title

The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4647475

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4647475

Other Identifiers

ISSN

1748-717X

E-ISSN

1748-717X

DOI

10.1186/s13014-015-0539-9

How to access this item